David J. Loskutoff

23.3k total citations · 3 hit papers
199 papers, 19.5k citations indexed

About

David J. Loskutoff is a scholar working on Cancer Research, Hematology and Immunology and Allergy. According to data from OpenAlex, David J. Loskutoff has authored 199 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Cancer Research, 98 papers in Hematology and 64 papers in Immunology and Allergy. Recurrent topics in David J. Loskutoff's work include Protease and Inhibitor Mechanisms (134 papers), Blood Coagulation and Thrombosis Mechanisms (94 papers) and Cell Adhesion Molecules Research (64 papers). David J. Loskutoff is often cited by papers focused on Protease and Inhibitor Mechanisms (134 papers), Blood Coagulation and Thrombosis Mechanisms (94 papers) and Cell Adhesion Molecules Research (64 papers). David J. Loskutoff collaborates with scholars based in United States, Japan and Germany. David J. Loskutoff's co-authors include Michael Sawdey, Fahumiya Samad, Peter Sartipy, Daniel A. Lawrence, Scott A. Curriden, Raymond R. Schleef, L.A. Erickson, Dietmar Seiffert, Thomas S. Edgington and Stavros Konstantinides and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David J. Loskutoff

198 papers receiving 18.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monocyte chemoattractant protein 1 in obesity and insulin resistance

2003 935 citations David J. Loskutoff et al. profile →
An Assay for Transforming Growth Factor-β Using Cells Transfected with a Plasminogen Activator Inhibitor-1 Promoter-Luciferase Construct

1994 677 citations David J. Loskutoff et al. profile →
Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.

1985 481 citations David J. Loskutoff et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Loskutoff United States	77	8.5k	7.0k	5.3k	3.3k	3.2k	199	19.5k
Désiré Collen Belgium	72	8.9k 1.0×	6.1k 0.9×	9.7k 1.8×	1.4k 0.4×	2.5k 0.8×	333	24.7k
D Collen Belgium	89	11.8k 1.4×	10.7k 1.5×	7.5k 1.4×	2.1k 0.6×	2.7k 0.9×	435	28.7k
Daniel A. Lawrence United States	65	6.5k 0.8×	4.3k 0.6×	4.6k 0.9×	1.7k 0.5×	1.6k 0.5×	215	13.1k
Ralph L. Nachman United States	62	3.4k 0.4×	6.6k 1.0×	5.8k 1.1×	2.7k 0.8×	750 0.2×	136	18.1k
Galina K. Sukhova United States	83	6.6k 0.8×	2.3k 0.3×	7.3k 1.4×	3.1k 0.9×	4.6k 1.4×	168	27.1k
Elaine W. Raines United States	72	3.4k 0.4×	1.7k 0.2×	10.4k 2.0×	3.6k 1.1×	1.8k 0.6×	142	23.3k
Eric Jaffe United States	38	2.3k 0.3×	3.5k 0.5×	5.5k 1.1×	2.3k 0.7×	673 0.2×	89	15.6k
Victor W.M. van Hinsbergh Netherlands	71	2.7k 0.3×	1.8k 0.3×	5.6k 1.1×	1.2k 0.4×	1.4k 0.4×	260	16.2k
Andrew S. Weyrich United States	70	1.6k 0.2×	4.8k 0.7×	4.1k 0.8×	1.7k 0.5×	1.6k 0.5×	169	15.2k
Wolfram Ruf United States	70	2.2k 0.3×	9.1k 1.3×	4.0k 0.8×	1.4k 0.4×	1.1k 0.3×	280	15.7k

Countries citing papers authored by David J. Loskutoff

Since Specialization

Citations

This map shows the geographic impact of David J. Loskutoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Loskutoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Loskutoff more than expected).

Fields of papers citing papers by David J. Loskutoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Loskutoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Loskutoff. The network helps show where David J. Loskutoff may publish in the future.

Co-authorship network of co-authors of David J. Loskutoff

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Loskutoff. A scholar is included among the top collaborators of David J. Loskutoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Loskutoff. David J. Loskutoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koschnick, Stefan, Stavros Konstantinides, Katrin Schäfer, Karen Crain, & David J. Loskutoff. (2005). Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin. Journal of Thrombosis and Haemostasis. 3(10). 2290–2295. 9 indexed citations

Takeshita, Kyosuke, Mutsuharu Hayashi, Shigeo Iino, et al.. (2004). Increased Expression of Plasminogen Activator Inhibitor-1 in Cardiomyocytes Contributes to Cardiac Fibrosis after Myocardial Infarction. American Journal Of Pathology. 164(2). 449–456. 101 indexed citations

Okumura, Yuushi, Yuichi Kamikubo, Scott A. Curriden, et al.. (2002). Kinetic Analysis of the Interaction between Vitronectin and the Urokinase Receptor. Journal of Biological Chemistry. 277(11). 9395–9404. 63 indexed citations

Konstantinides, Stavros, Katrin Schäfer, T Thinnes, & David J. Loskutoff. (2001). Plasminogen Activator Inhibitor-1 and Its Cofactor Vitronectin Stabilize Arterial Thrombi After Vascular Injury in Mice. Circulation. 103(4). 576–583. 148 indexed citations

Schäfer, Katrin, et al.. (2001). Disruption of the plasminogen activator inhibitor‐1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice. The FASEB Journal. 15(10). 1840–1842. 145 indexed citations

Loskutoff, David J., Scott A. Curriden, Geng Hu, & Gang Deng. (1999). Regulation of cell adhesion by PAI‐1. Apmis. 107(1-6). 54–61. 129 indexed citations

Yamamoto, Kazutoshi & David J. Loskutoff. (1997). The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis.. Europe PMC (PubMed Central). 151(3). 725–34. 28 indexed citations

Seiffert, Dietmar, Gerald M. Bordin, & David J. Loskutoff. (1996). Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes. Histochemistry and Cell Biology. 105(3). 195–201. 18 indexed citations

Deng, Gang, et al.. (1996). Structural and Functional Analysis of the Plasminogen Activator Inhibitor-1 Binding Motif in the Somatomedin B Domain of Vitronectin. Journal of Biological Chemistry. 271(22). 12716–12723. 90 indexed citations

10.

Keeton, M, et al.. (1995). Expression of type 1 plasminogen activator inhibitor in renal tissue in murine lupus nephritis. Kidney International. 47(1). 148–157. 43 indexed citations

11.

Fearns, Colleen, Vladimir V. Kravchenko, Richard J. Ulevitch, & David J. Loskutoff. (1995). Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide.. The Journal of Experimental Medicine. 181(3). 857–866. 136 indexed citations

12.

Tipping, Peter G., Jonathan Erlich, Jim Apostolopoulos, et al.. (1995). Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA.. PubMed. 147(6). 1736–48. 44 indexed citations

13.

Lang, Iréne, et al.. (1994). Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli.. Circulation. 89(6). 2715–2721. 81 indexed citations

14.

Eddleston, Michael, Juan Carlos de la Torre, Michael B. A. Oldstone, et al.. (1993). Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis.. Journal of Clinical Investigation. 92(1). 349–358. 124 indexed citations

15.

Wagner, Steven L., Alice Lau, Ann Nguyen, et al.. (1991). Inhibitors of Urokinase and Thrombin in Cultured Neural Cells. Journal of Neurochemistry. 56(1). 234–242. 21 indexed citations

16.

Seiffert, Dietmar, Jun Mimuro, Raymond R. Schleef, & David J. Loskutoff. (1990). Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin. Cell Differentiation and Development. 32(3). 287–292. 51 indexed citations

17.

Schleef, Raymond R., M P Bevilacqua, Michael Sawdey, Michael A. Gimbrone, & David J. Loskutoff. (1988). Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.. Journal of Biological Chemistry. 263(12). 5797–5803. 475 indexed citations

18.

Schleef, Raymond R. & David J. Loskutoff. (1988). Fibrinolytic System of Vascular Endothelial Cells. Pathophysiology of Haemostasis and Thrombosis. 18(4-6). 328–341. 114 indexed citations

19.

Levin, Eugene G. & David J. Loskutoff. (1980). Serum-mediated suppression of cell-associated plasminogen activator activity in cultured endothelial cells. Cell. 22(3). 701–707. 41 indexed citations

20.

Loskutoff, David J., et al.. (1978). Membrane characteristics of cultured endothelial cells: identification of gap junction.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(3). 306–13. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact